Continuous regional arterial infusion therapy for acute necrotizing pancreatitis due to Mycoplasma pneumoniae infection in a child

Cardiovasc Intervent Radiol. 2009 May;32(3):581-4. doi: 10.1007/s00270-008-9457-7. Epub 2008 Oct 28.

Abstract

A case of acute necrotizing pancreatitis due to Mycoplasma pneumoniae infection was treated in an 8-year-old girl. She experienced acute pancreatitis during treatment for M. pneumoniae. Contrast-enhanced computed tomographic scan revealed necrotizing pancreatitis. The computed tomographic severity index was 8 points (grade E). A protease inhibitor, ulinastatin, was provided via intravenous infusion but was ineffective. Continuous regional arterial infusion therapy was provided with gabexate mesilate (FOY-007, a protease inhibitor) and meropenem trihydrate, and the pancreatitis improved. This case suggests that infusion therapy is safe and useful in treating necrotizing pancreatitis in children.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Child
  • Contrast Media
  • Drug Therapy, Combination
  • Female
  • Gabexate / administration & dosage
  • Gabexate / therapeutic use*
  • Humans
  • Infusions, Intra-Arterial*
  • Meropenem
  • Mycoplasma pneumoniae / isolation & purification*
  • Pancreatitis, Acute Necrotizing / drug therapy*
  • Pancreatitis, Acute Necrotizing / microbiology*
  • Pneumonia, Mycoplasma / complications*
  • Serine Proteinase Inhibitors / administration & dosage
  • Serine Proteinase Inhibitors / therapeutic use*
  • Thienamycins / administration & dosage
  • Thienamycins / therapeutic use*
  • Tomography, X-Ray Computed

Substances

  • Anti-Bacterial Agents
  • Contrast Media
  • Serine Proteinase Inhibitors
  • Thienamycins
  • Gabexate
  • Meropenem